| Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model TF Rogers, F Zhao, D Huang, N Beutler, A Burns, W He, O Limbo, C Smith, ... Science 369 (6506), 956-963, 2020 | 1335 | 2020 |
| Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death X Chen, W Li, J Ren, D Huang, W He, Y Song, C Yang, W Li, X Zheng, ... Cell research 24 (1), 105-121, 2014 | 790 | 2014 |
| Broad neutralization of SARS-related viruses by human monoclonal antibodies AZ Wec, D Wrapp, AS Herbert, DP Maurer, D Haslwanter, M Sakharkar, ... Science 369 (6504), 731-736, 2020 | 540 | 2020 |
| Structural basis of a shared antibody response to SARS-CoV-2 M Yuan, H Liu, NC Wu, CCD Lee, X Zhu, F Zhao, D Huang, W Yu, Y Hua, ... Science 369 (6507), 1119-1123, 2020 | 528 | 2020 |
| RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome Y Zhang, SS Su, S Zhao, Z Yang, CQ Zhong, X Chen, Q Cai, ZH Yang, ... Nature communications 8 (1), 14329, 2017 | 437 | 2017 |
| Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants M Yuan, D Huang, CCD Lee, NC Wu, AM Jackson, X Zhu, H Liu, L Peng, ... Science 373 (6556), 818-823, 2021 | 346 | 2021 |
| Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate S Bangaru, G Ozorowski, HL Turner, A Antanasijevic, D Huang, X Wang, ... Science 370 (6520), 1089-1094, 2020 | 317 | 2020 |
| A role of RIP3-mediated macrophage necrosis in atherosclerosis development J Lin, H Li, M Yang, J Ren, Z Huang, F Han, J Huang, J Ma, D Zhang, ... Cell reports 3 (1), 200-210, 2013 | 298 | 2013 |
| Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody CG Rappazzo, LV Tse, CI Kaku, D Wrapp, M Sakharkar, D Huang, ... Science 371 (6531), 823-829, 2021 | 283 | 2021 |
| Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection G Song, W He, S Callaghan, F Anzanello, D Huang, J Ricketts, JL Torres, ... Nature communications 12 (1), 2938, 2021 | 271 | 2021 |
| Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling W Chen, Z Zhou, L Li, CQ Zhong, X Zheng, X Wu, Y Zhang, H Ma, ... Journal of Biological Chemistry 288 (23), 16247-16261, 2013 | 270 | 2013 |
| The MLKL channel in necroptosis is an octamer formed by tetramers in a dyadic process D Huang, X Zheng, Z Wang, X Chen, W He, Y Zhang, JG Xu, H Zhao, ... Molecular and cellular biology 37 (5), e00497-16, 2017 | 136 | 2017 |
| A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection P Zhou, M Yuan, G Song, N Beutler, N Shaabani, D Huang, W He, X Zhu, ... Science translational medicine 14 (637), eabi9215, 2022 | 128 | 2022 |
| PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing AL Gavin, D Huang, C Huber, A Mårtensson, V Tardif, PD Skog, TR Blane, ... Nature immunology 19 (9), 942-953, 2018 | 92 | 2018 |
| HIV-1 vaccine design through minimizing envelope metastability L He, S Kumar, JD Allen, D Huang, X Lin, CJ Mann, KL Saye-Francisco, ... Science advances 4 (11), eaau6769, 2018 | 84 | 2018 |
| Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern H Cho, KK Gonzales-Wartz, D Huang, M Yuan, M Peterson, J Liang, ... Science translational medicine 13 (616), eabj5413, 2021 | 82 | 2021 |
| Reprogramming the antigen specificity of B cells using genome-editing technologies JE Voss, A Gonzalez-Martin, R Andrabi, RP Fuller, B Murrell, LE McCoy, ... Elife 8, e42995, 2019 | 78 | 2019 |
| Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells D Huang, JT Tran, A Olson, T Vollbrecht, M Tenuta, MV Guryleva, ... Nature communications 11 (1), 5850, 2020 | 71 | 2020 |
| Commercial serology assays predict neutralization activity against SARS-CoV-2 RT Suhandynata, MA Hoffman, D Huang, JT Tran, MJ Kelner, SL Reed, ... Clinical chemistry 67 (2), 404-414, 2021 | 66 | 2021 |
| A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody NC Wu, M Yuan, S Bangaru, D Huang, X Zhu, CCD Lee, HL Turner, ... PLoS pathogens 16 (12), e1009089, 2020 | 64 | 2020 |
David NemazeeThe Scripps Research InstituteVerified email at scripps.edu
